Evidence map›Paper›PMID 40375823›Full record

ArticleChemMedChem2025

Impact of Chelation on Reactivity and Cytotoxicity of Hemilabile Biphenyl Gold(III) N-Heterocyclic Carbene Complexes.

Tom Lacoma, Jérémy Forté, Régina Maruchenko, Romain Morichon, Michèle Salmain, Joëlle Sobczak-Thépot, Benoît Bertrand

Abstract read
In one paragraph

Article in ChemMedChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tom LacomaInstitut Parisien de Chimie Moléculaire (IPCM), Sorbonne Université, CNRS, 4 place Jussieu, F-75005, Paris, France.ORCID https://orcid.org/0009-0007-0501-3213
Jérémy FortéInstitut Parisien de Chimie Moléculaire (IPCM), Sorbonne Université, CNRS, 4 place Jussieu, F-75005, Paris, France.ORCID https://orcid.org/0000-0002-9363-4162
Régina MaruchenkoInstitut Parisien de Chimie Moléculaire (IPCM), Sorbonne Université, CNRS, 4 place Jussieu, F-75005, Paris, France.
Romain MorichonCentre de Recherche Saint Antoine (CRSA), Sorbonne Université, INSERM, 184 rue du Faubourg Saint Antoine, F-75 012, Paris, France.
Michèle SalmainInstitut Parisien de Chimie Moléculaire (IPCM), Sorbonne Université, CNRS, 4 place Jussieu, F-75005, Paris, France.ORCID https://orcid.org/0000-0003-3039-5659
Joëlle Sobczak-ThépotCentre de Recherche Saint Antoine (CRSA), Sorbonne Université, INSERM, 184 rue du Faubourg Saint Antoine, F-75 012, Paris, France.ORCID https://orcid.org/0000-0001-7180-2789
Benoît BertrandInstitut Parisien de Chimie Moléculaire (IPCM), Sorbonne Université, CNRS, 4 place Jussieu, F-75005, Paris, France.ORCID https://orcid.org/0000-0003-0542-4454

Funding

Aviesan ITMO-Cancer 23CP039-00Centre National de la Recherche ScientifiqueInstitut National de la Santé et de la Recherche MédicaleSorbonne Université
6 · The paper itself

Abstract

Although great progresses have been accomplished in the field of antineoplastic treatments, the need for chemotherapy agents with new mechanisms of action remains essential. Metal complexes presenting hemilabile ligands could combine structural toxicity upon full coordination of the ligand and reactive toxicity upon ligand partial decoordination and direct coordination of the metal center to biological targets. To investigate the relevance of hemilability in the case of Au(III) complexes, we synthesized eight open biphenyl gold(III) N-heterocyclic carbene complexes coined BGC of general formula [(C^C)Au(NHC^het)Cl] where het is a pyridine-type entity and C^C is 4,4'-diterbutylbiphenyl. Chloride abstraction afforded the chelated cationic complexes [(C^C)Au(NHC^N)]PF

Indexed as

Antineoplastic AgentsBiphenyl CompoundsChelating AgentsCoordination ComplexesGoldHeterocyclic CompoundsMethaneApoptosisCell Line, TumorCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorHumansMolecular StructureStructure-Activity RelationshipAntineoplastic AgentsbiphenylBiphenyl CompoundscarbeneChelating AgentsCoordination ComplexesGoldHeterocyclic CompoundsMethanecytotoxicitygoldhemilabileorganometallicreactivity

Identifiers

PMID40375823
PMCPMC12276038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.